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ABSTRACTSyear survival estimates, but follow up limits comparison of actual survival.
However, a recent study has suggested that 2 year follow up data corre-
lates well with 5-year survival.
0486: "SATURATION PROSTATE BIOPSY IN PATIENTS WITH RAISED AGE-
RELATED PSA AND NON-MALIGNANT PREVIOUS TRUS BIOPSIES"
Michelle Christodoulidou, Mohsen El-Gammal. Southport and Ormskirk
Hospital NHS Trust, Southport,Merseyside, UK
Aim: To review the demographic data of patients that underwent Satu-
ration Prostate Biopsies over an 18 month period with emphasis on the
indications, antibiotic cover, complications and histological outcome.
Method: Patients were traced by the Theatres Register and GALAXY
system. Data were collected from case notes.
Results: 28 Saturation Biopsies were performed between July 2010 and
December 2011. Median age was 67, 54% of patients had LUTS and 7% had
family history of prostate cancer. 14% had abnormal DRE. Median value of 2
TRUS biopsies were taken prior to the Saturation Biopsy. All patients were
given 160mg Gentamicin IV and a 3 day course of Ciproﬂoxacin orally. Only
one case presentedwith Urosepsis requiring IV antibiotics. Saturation biopsy
diagnosedmalignancy in36%ofpatients.1patientwhohadbenign saturation
biopsy subsequently underwent a Template biopsy that showedmalignancy.
Conclusions: Saturation Biopsy is useful in diagnosing prostate cancer in
about 36% of cases after 2 inconclusive TRUS Biopsies. The pick up rate of
cancer is higher than a 3rd TRUS biopsy. The currently adopted antibiotic
prophylaxis appears appropriate with 3.6% risk of urosepsis. When Satu-
ration Biopsy is non malignant and PSA is still rising, template biopsy
maybe considered.
0524: USE OF THE SWOP CALCULATOR TO REDUCE UNNECESSARY
PROSTATE BIOPSIES IN MEN WITH ELEVATED PSA
Andrew Birch 1, John Withington 1, Janette Kinsella 2, Peter Acher 1, Ben
Challacombe 2. 1 East Sussex Healthcare NHS Trust, East Sussex, UK; 2Guy's
and St. Thomas' NHS Foundation Trust, London, UK
Background: The SWOP calculator is a nomogram derived from the Euro-
pean Randomised Study of Screening for Prostate Cancer which predicts the
percentage probability ofmalignant prostate biopsy by using the variables of
age, DRE ﬁnding, PSA, ultrasound appearance and prostate volume.
Aim: To investigate whether using a 10% or 15% risk threshold could avert
unnecessary biopsies.
Method: Data from 207 eligible patients (median age 60) biopsied from
2004-2010 were entered retrospectively into the risk calculator. The clin-
ical outcomes for patients with 15% SWOP risk were investigated.
Results: Of the 42 patients with 15% SWOP risk 13 patients (31%) had
malignant histology at biopsy (9 Gleason 3+3, 4 Gleason 3+4), 7 received
radical treatment (5 radical prostatectomies, 2 brachytherapy) and 5
entered active surveillance.
Of the 17 patients with a SWOP risk 10% 4 (24%) had positive biopsies
(Gleason 3+3); none required treatment, 3 entered active surveillance (one
patient has no follow-up data).
Conclusions: These data show that were a 15% risk threshold applied, then
signiﬁcant prostate cancers requiring treatment would have been missed
but a 10% risk-threshold may have avoided unnecessary biopsies.
The SWOP calculator may be useful for avoiding unnecessary biopsies in
low-risk patients; this has signiﬁcant implications for reducing biopsy and
treatment morbidity and cost.
0551: TRANSPERINEAL TEMPLATE-GUIDED SATURATION BIOPSIES OF
THE PROSTATE – EARLY EXPERIENCES IN A DISTRICT GENERAL
HOSPITAL OF A NOVEL TECHNIQUE OF SATURATION BIOPSY
Jaspal Phull, Alison Townsend, Megan Whitaker, Llinos Davies, Andy
Thomas. Princess of Wales Hospital, Bridgend, UK
Aims: Transrectal ultrasound-guided (TRUS) biopsy may miss 30% of
signiﬁcant prostate cancer, likely to be in the anterior zone. Transperineal
template-guided saturation biopsies (TTB) is a NICE approved means of
saturation-biopsy. We assessed detection rates with TTB.
Methods: A prospective, non-randomized, cohort study of TTBs between
July 2010 and August 2011. All cases were peer-reviewed at MDT, and
would seek radical treatment if positive.
The primary outcome was detection of malignancy.Results: 22 TTBs were performed. 81.8% (n¼18) had >1 negative TRUS, 9.1%
(n¼2) were on active surveillance, 4.5% (n¼1) was post-radiotherapy PSA-
relapse, and 4.5% (n¼1) chose to have TTB as the primary biopsy method.
12 of the 22 cases (54.5%) had new-diagnosis carcinoma only detected at
TTB. 7 were benign (31.8%).
Of the malignant histology (n¼15) 13.3% were Gleason 6 (n¼2), 73.3% were
Gleason 7 (n¼11), and 13.3% were Gleason 8 carcinomas (n¼2).
Conclusion: TTB should be considered for men with rising PSAs and
negative TRUS biopsy. We advocate TTB as the preferred technique for
saturation biopsy for detection of signiﬁcant prostate cancer in men who
would beneﬁt from further treatment.
0572: OUT-PATIENT FLEXIBLE CYSTOSCOPY CAUSES PSYCHOLOGICAL
DISTRESS TO A SIGNIFICANT NUMBER OF PATIENTS BEING
INVESTIGATED FOR BLADDER CANCER
Gidon Ellis 1, Jamie Fairweather 1, Ninaad Awsare 2, Sam Osaghae 3, Sam
Smith 4, Thomas McNicholas 5, James Green 1. 1Whipps Cross University
Hosptial, London, UK; 2Morriston Hospital, Swansea, UK; 3 Pilgrim Hospital,
Lincolnshire, UK; 4University College London, London, UK; 5 Lister Hospital,
Stevenage, UK
Introduction: Many patients undergoing outpatient ﬂexible cystoscopy
experience psychological distress. This may relate to the impending
procedure and to the possibility of discovering cancer. We set out to
investigate the prevalence of signiﬁcant psychological distress in a cohort
of patients undergoing ﬂexible cystoscopy and to identify subsets of the
population who may be at higher risk.
Methods: We recruited 173 patients undergoing out-patient ﬂexible
cystoscopywho completed questionnaires containing the Hospital Anxiety
and Depression Score-A (HADS) and HADS-D to assess anxiety and
depression respectively. A score of 11/21 on either scale was regarded as
clinically signiﬁcant.
Results: The overall prevalence of anxiety was 15%, which was higher in
females (p¼0.025), in the young (p¼0.001) and in unmarried individuals
(p¼ 0.02). The prevalence of depressionwas 3.5%, which was higher in the
young (0.001) and in unmarried individuals (p¼0.02).
Conclusion: The prevalence of clinically signiﬁcant anxiety and depression
in this cohort is notable; in particular amongst women, younger and
unmarried patients. Accelerating the diagnostic pathway, improving
patient information and offering counselling to those affected may help to
reduce distress. Resources could be targeted at the higher risk groups
identiﬁed here. The HADS questionnaires are a useful ﬁrst-line screening
tool for psychological distress.
0605: SMALL SIZE NEPHROSTOMY TUBE USE POST PCNL
Ben Rossi, Michal Sut, Asheesh Kaul, Abdul Rahim Khan, Aasem
Chaudry. Bedford Hospital NHS Trust, Bedford, UK
Objective: To assess safety and outcomes of a small size 8F/8.5F neph-
rostomy tube use following Percutaneous Nephrolithotomy.
Materials and methods: Retrospective data collection from 15 PCNL cases
performed in Bedford Hospital NHS Trust over a period of 10months. Stone
clearance, hospital stay, complication rate, hemoglobin drop, analgesia and
transfusion requirements were reviewed. Data was compared to recently
published outcomes for tubeless PCNL and large bore nephrostomy use.
Results: Median hemoglobin drop was 1.3 g.dL and length of stay was 72
hours. Those were comparable to previously reported results for tubeless
PCNLand large borenephrostomy tubeuse. Complication ratewas lowat 13%
with only one patient requiring admission and treatment for urinary sepsis
and one patient requiring repeat procedure due to pain related to residual
stone. Stone clearance on day 1was 60%. Average analgesia requirementwas
1050mg of tramadol which was signiﬁcantly higher than in previously re-
ported studies and was likely related to our prescribing protocol.
Conclusions: Small size nephrostomy PCNL is a safe procedure with
acceptable Hb drop and length of stay. Decreased analgesia requirements
proven previously were not reproduced in our group of patients.
0622: UROLOGY CANCER PATIENTS' VIEWS ON MULTIDISCIPLINARY
TEAM (MDT) WORKING. A PILOT STUDY
Benjamin Lamb 1, Rozh Jalil 1, Sujay Shah 1, James Green 2, Paula
Allchorne 2, Nick Sevdalis 1. 1 Imperial College, London, UK; 2Whipps Cross
University Hospital, London, UK
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ABSTRACTSIntroduction: Patient-centred care and patient satisfaction are increas-
ingly recognised as being integral to high quality urological care. However,
little evidence exists for whether the understanding experience of patients
reﬂects the perceptions of healthcare professionals. This study aimed to
explore urology patients' experience of the urology MDT.
Method: Focus groups were set up to explore qualitatively participants'
experiences and opinions. Questions covered patients' experience of
being treated by a urology-MDT, awareness of the MDT's role, informa-
tion the MDT should consider, and patient representation at MDT
meetings.
Results: Three focus groups were attended by 21 participants. Aware-
ness of the MDT was low, but participants found the idea reassuring.
Participants felt that it was important for the MDT to consider
psychosocial information and their preferences, although this was not
always their experience. Participants felt that the urology specialist
nurse should act as their advocate in the meeting and that case
discussion should be delayed if no one who had seen and knew the
patient was present.
Discussion: The concept of the MDT is popular with patients and could be
promoted to increase patient satisfaction and improve patient experience.
Further research is needed to link patients' MDT views with patient
outcome and experience measures.
0630: RELIABILITY OF TRUS CALCULATIONS OF PROSTATE VOLUME
Kaylie Hughes, David Ellis, Richard Stephenson. Wirral University Teaching
Hospital NHS Foundation Trust, Wirral, UK
Aim: Prostate size is an important parameter in the assessment and
treatment of prostate cancer. Prostate speciﬁc antigen (PSA) density can
inﬂuence investigation approach and volume limits are often included in
acceptance criteria for template biopsy and brachytherapy. We aim to
assess the accuracy of volumes calculated by trans-urethral ultrasound
(TRUS) compared with those from MRI.
Method: All patients in our hospital undergoing TRUS imaging and pros-
tatic biopsies were identiﬁed for the period of twelve months from
December 2010 to 2011. Our standard protocol for potential candidates for
curative therapy includes MRI quickly followed by TRUS biopsy. This allows
a reasonable timeframe for comparison. Sizes were calculated using the
standard ellipse method.
Findings: We identiﬁed 196 patients for whom MRI and TRUS volumes
were documented within six weeks of each other. Results were compared
with a Wilcoxon-signed rank test. No signiﬁcant difference was identiﬁed
(p¼0.108).
Conclusion: Our results suggest that MRI prostate offers no added beneﬁt
when it comes to measuring prostate size. We feel that consistency
between volumes produced by different imaging modalities is more
important than absolute precision, as any thresholds will have been
derived from the same methods.
0646: IS THE FREE/TOTAL PSA RATIO USEFUL AT PREDICTING THE
PRESENCE OF PROSTATE CANCER ON TRANSPERINEAL PROSTATE
MAPPING BIOPSIES?
Neil Kotecha, Shahid Aziz Anwar Khan, A.M Emara, S.R.J. Bott, R.G
Hindley. Hampshire Hospital, Basingstoke, UK
Aim: We evaluated the role of Free/Total (F/T) PSA ratio in improving the
prediction of prostate cancer in the transperineal prostate mapping biopsy
(TPM) setting.
Methods: The F/T PSA ratiowere available in 145 patients with a total PSA<
20ng/ml. All patients underwent a standard TPM under GA. The cancer
detection rate, pathologic features of the cancers detected, and the prob-
ability of cancer detection in relation to the F/T PSA ratio were estimated.
Results: Mean Age and PSA were 64.4 years and 9.5ng/l respectively
(Range 1.6-20ng/ml). Overall cancer detection rate was 51.8%. 55/145 had
a F/T ratio < 10 % of which 34/55 (61.8%) conﬁrmed cancer (n¼10 had
Gleason 7, n¼24 had Gleason 6). 66/145 had a F/T PSA ratio between 10-
20% with 50% of them having positive biopsies (n¼26 had Gleason 6, n¼38
had Gleason 7 and only 2 had Gleason 8). 24/145 had a F/T PSA ratio > 20%
and only 1/3 had evidence of cancer (all Gleason 6).
Conclusion: The F/T PSA ratio in our series failed to confer a signiﬁcant
beneﬁt in improving the cancer detection rate. However, in patients with
a ratio of >20% only 1/3 had cancer present but were of a favourable grade.0682: FEASIBILITY OF RANDOMISATION IN THE RANDOMISED
CONTROLLED TRIAL OF OPEN, ROBOTIC AND LAPAROSCOPIC (CORAL)
RADICAL CYSTECTOMY TRIAL
Grace Cheung, Amit Patel, Fahim Ismail, Peter Rimmington, Shamim
Khan, Prokar Dasgupta. Guy's Hospital, London, UK
Introduction: Minimally-invasive techniques for radical cystectomy are
increasing in prevalence in the urological community. However, current
evidence is lacking in which surgical technique is best.
Methods: A single-centre randomised-controlled trial comparing open,
laparoscopic and robotic-assisted radical cystectomy (RARC) for muscle-
invasive or high-grade bladder cancer is currently underway at our centre, to
investigate the short and long-term outcomes for each of these techniques.
Results: 83 patients were eligible to be enrolled in the trial since March
2009. 54 patients agreed to participate.
There was no difference between the trial and non-trial patients in terms
of age (<70 years compared with > 70 years, p¼0.8), gender or body mass
index (BMI) (BMI<25 compared with BMI > 25, p¼0.5).
Of the non-trial patients, 13 chose open cystectomy and 16 chose RARC.
None in this group chose the laparoscopic technique.
Conclusion: The majority of eligible patients agreed to random allocation,
and there appears to be no difference between non-trial participants
towards choosing an open or robotic approach. There is no obvious
selection bias in terms of age, gender or BMI for randomisation in this trial.
0704: LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH BENIGN
RENAL DISEASE AND ITS EFFECT ON HYPERTENSION
Anna Mainwaring, Ninaad Awsare, Neil Fenn. Morriston Hospital, Swansea,
UK
Aim:We investigated the safety and efﬁcacy of laparoscopic nephrectomy
(LN) in the treatment of refractory hypertension in patients with a unilat-
eral poorly functioning kidney.
Method: A retrospective review of patients undergoing laparoscopic simple
nephrectomy for benign disease between 2005 and 2011 was performed
using information from hospital and general practice patient records,
operating theatre and pathology databases. 49 patients underwent LN for
the following indications: (n¼13) difﬁculty controlling hypertension, (n¼20)
chronic renal pain, (n¼11) recurrent urinary tract infection and (n¼5) had
both pain/infection. Data collected included operative details, complications
recorded using the Clavien Classiﬁcation and symptom control.
Results: All procedures were completed laparoscopically with no open
conversions. There was no change in post operative creatinine levels.
Complications occurred in 10(20%) patients with Clavien Classiﬁcation as;
Grade 1:(4) patients; Grade 2:(4) patients, Grade 3b:(1) patient, Grade
4:(1) patient. In the hypertension group therewas no immediate reduction
in post-operative blood pressure, however on follow up 2(15%) stopped all
antihypertensive medication, 6(46%) reduced their medication with no
change in 5(39%) patients.
Conclusions: Laparoscopic nephrectomy for symptomatic benign renal
disease is safe. The high success rate in reduction of antihypertensive
medication conﬁrms its efﬁcacy and provides useful information when
counselling patients preoperatively.
0716: THE SURGICAL CARE PRACTITIONER – ASSISTING, NOT
COMPETING WITH, THE EXPERIENCED REGISTRAR AS PART OF
MODULAR TRAINING FOR OPEN RADICAL RETROPUBIC-
PROSTATECTOMY
James Osborne, Jaspal Phull, Jim Wilson, Adam Carter. Royal Gwent
Hospital, Newport, UK
Aim: Open radical retropubic-prostatectomy (RRP) requires both an
experienced surgeon and assistant. We compare a Surgical Care Practi-
tioner (SCP) as primary assistant against an experienced SpR (Syear4)
assistant. We test the feasibility of using a SCP as assistant to a senior SpR
in RRP by comparing their respective outcomes as ﬁrst assistant.
Methods: Retrospective review of all RRPs between January 2010 and
October 2011. The ﬁrst assistant was recorded (SCP or SpR). Outcomes
were (1) intra-operative re-transfusion volume, (2) post-operative hae-
moglobin drop, and (3) operating time.
Results: 99 RRPs were identiﬁed. 91 cases were suitable for analysis. The
ﬁrst assistant was the SCP in n¼55 and Year 4/5 SpR in n¼36.
